Rapid Differentiation of Joint Infections

Accurate and rapid differentiation between postoperative inflammation and infection is critical, yet difficult with current diagnostic methods.

The global joint replacement market is projected to reach $38 billion by 2030. With the rising number of joint replacement surgeries, the demand for effective infection diagnostics is increasing, presenting a substantial market opportunity for SynoTact®.

SynoTact® helps surgeons quickly differentiate between post-operative inflammation or bacterial infections, whether immediately or during follow-ups.

SynoTact® is designed for acute and chronic PJI detection, providing fast, reliable results from synovial fluid analysis to prevent unnecessary antibiotic use, reducing antibiotic resistance and avoiding prolonged hospital stays.